Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia
Overview
General Medicine
Authors
Affiliations
Previous studies suggest that the diversity of the expressed variable (V) region repertoire of the immunoglobulin (Ig)H chain of B-CLL cells is restricted. Although limited examples of marked constraint in the primary structure of the H and L chain V regions exist, the possibility that this level of restriction is a general principle in this disease has not been accepted. This report describes five sets of patients, mostly with unmutated or minimally mutated IgV genes, with strikingly similar B cell antigen receptors (BCRs) arising from the use of common H and L chain V region gene segments that share CDR3 structural features such as length, amino acid composition, and unique amino acid residues at recombination junctions. Thus, a much more striking degree of structural restriction of the entire BCR and a much higher frequency of receptor sharing exists among patients than appreciated previously. The data imply that either a significant fraction of B-CLL cells was selected by a limited set of antigenic epitopes at some point in their development and/or that they derive from a distinct B cell subpopulation with limited Ig V region diversity. These shared, stereotyped Ig molecules may be valuable probes for antigen identification and important targets for cross-reactive idiotypic therapy.
Autoimmunity promotes chronic lymphocytic leukemia progression in an indolent disease model.
Pfeuffer L, Siegert V, Trozzo R, Steiger K, Rad R, Ruland J Sci Rep. 2025; 15(1):4117.
PMID: 39900937 PMC: 11791097. DOI: 10.1038/s41598-025-86876-1.
Stereotyped B-Cell Receptor Immunoglobulins in B-Cell Lymphomas.
Agathangelidis A, Roussos A, Kardamiliotis K, Psomopoulos F, Stamatopoulos K Methods Mol Biol. 2024; 2865:125-143.
PMID: 39424723 DOI: 10.1007/978-1-0716-4188-0_6.
Expression Cloning of Antibodies from Single Human B Cells.
Rollenske T, Murugan R, Wardemann H, Busse C Methods Mol Biol. 2024; 2865:103-124.
PMID: 39424722 DOI: 10.1007/978-1-0716-4188-0_5.
Stamatopoulos K, Pavlova S, Al-Sawaf O, Chatzikonstantinou T, Karamanidou C, Gaidano G Hemasphere. 2024; 8(7):e113.
PMID: 39035106 PMC: 11260284. DOI: 10.1002/hem3.113.
An overview of prognostic markers in patients with CLL.
Braish J, Cerchione C, Ferrajoli A Front Oncol. 2024; 14():1371057.
PMID: 38817892 PMC: 11137234. DOI: 10.3389/fonc.2024.1371057.